| Shannon D Gates, MD | |
|
1344 Wintergreen Ln Ne Ste 100, Bainbridge Island, WA 98110-5118 | |
| (206) 201-0488 | |
| Not Available |
| Full Name | Shannon D Gates |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 1344 Wintergreen Ln Ne Ste 100, Bainbridge Island, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710151238 | NPI | - | NPPES |
| 2130389 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A103930 (California) | Secondary |
| 207P00000X | Emergency Medicine | MD60612568 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harrison Medical Center | Bremerton, WA | Hospital |
| St Joseph Medical Center | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
St Petersburg University researchers, led by Professor Raul R. Gainetdinov, Director of the Institute of Translational Biomedicine and Academic Supervisor of the St Petersburg University Hospital, have found a new role for recently discovered neurotransmitter system that uses the trace amine-associated receptor 5 (TAAR5) for neurotransmission.
More than one in four kindergarten children, and one in five teachers, had difficulty distinguishing between medicine and candy in new research conducted by two, now seventh-grade students, who presented their findings on Monday, Oct. 17, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston.
In recent years, Cycloxygenase (COX)-2 has emerged as a therapeutic target for the prevention and treatment of various types of cancers.
It's Groundhog Day in Congress, where lawmakers appear to have glimpsed their shadows and are entering a newly intense period of negotiations over whether to extend the payroll tax cut that is shaping up to be remarkably similar to a bruising December fight over the same issue.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced that it has secured a loan from Takeda Research Investment (TRI) which Envoy may elect to convert to Envoy preferred stock should the company complete a second private equity financing. TRI will receive certain rights from Envoy related to a specific therapeutic field while scientists at the two companies craft a broad scientific research alliance.
› Verified 1 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
St Petersburg University researchers, led by Professor Raul R. Gainetdinov, Director of the Institute of Translational Biomedicine and Academic Supervisor of the St Petersburg University Hospital, have found a new role for recently discovered neurotransmitter system that uses the trace amine-associated receptor 5 (TAAR5) for neurotransmission.
More than one in four kindergarten children, and one in five teachers, had difficulty distinguishing between medicine and candy in new research conducted by two, now seventh-grade students, who presented their findings on Monday, Oct. 17, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston.
In recent years, Cycloxygenase (COX)-2 has emerged as a therapeutic target for the prevention and treatment of various types of cancers.
It's Groundhog Day in Congress, where lawmakers appear to have glimpsed their shadows and are entering a newly intense period of negotiations over whether to extend the payroll tax cut that is shaping up to be remarkably similar to a bruising December fight over the same issue.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced that it has secured a loan from Takeda Research Investment (TRI) which Envoy may elect to convert to Envoy preferred stock should the company complete a second private equity financing. TRI will receive certain rights from Envoy related to a specific therapeutic field while scientists at the two companies craft a broad scientific research alliance.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shannon D Gates, MD 1344 Wintergreen Ln Ne Unit 100, Bainbridge Island, WA 98110-5147 Ph: (206) 201-0488 | Shannon D Gates, MD 1344 Wintergreen Ln Ne Ste 100, Bainbridge Island, WA 98110-5118 Ph: (206) 201-0488 |
News Archive
St Petersburg University researchers, led by Professor Raul R. Gainetdinov, Director of the Institute of Translational Biomedicine and Academic Supervisor of the St Petersburg University Hospital, have found a new role for recently discovered neurotransmitter system that uses the trace amine-associated receptor 5 (TAAR5) for neurotransmission.
More than one in four kindergarten children, and one in five teachers, had difficulty distinguishing between medicine and candy in new research conducted by two, now seventh-grade students, who presented their findings on Monday, Oct. 17, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston.
In recent years, Cycloxygenase (COX)-2 has emerged as a therapeutic target for the prevention and treatment of various types of cancers.
It's Groundhog Day in Congress, where lawmakers appear to have glimpsed their shadows and are entering a newly intense period of negotiations over whether to extend the payroll tax cut that is shaping up to be remarkably similar to a bruising December fight over the same issue.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced that it has secured a loan from Takeda Research Investment (TRI) which Envoy may elect to convert to Envoy preferred stock should the company complete a second private equity financing. TRI will receive certain rights from Envoy related to a specific therapeutic field while scientists at the two companies craft a broad scientific research alliance.
› Verified 1 days ago
Dr. Daniel Caleb Sheffield, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1344 Wintergreen Lane, Ste 100, Bainbridge Island, WA 98110 Phone: 206-201-0488 Fax: 206-201-0490 |